Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5317-5322, October 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasbaoui, L.
Right arrow Articles by Meflah, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasbaoui, L.
Right arrow Articles by Meflah, K.

Differences in Glycosylation State of Fibronectin from Two Rat Colon Carcinoma Cell Lines in Relation to Tumoral Progressiveness1

Laila Kasbaoui, Jean Harb, Serge Bernard and Khaled Meflah2

Laboratoire de Biochimie Médicale, UFR de Médecine, 1 rue Gaston Veil, 44035 Nantes Cedex, France

We have investigated the biosynthesis and carbohydrate structure of fibronectin secreted by two rat colon carcinoma cell lines. The cell line Prob yields progressive tumors after s.c. injection in syngeneic BD IX rats while tumors developed by Regb cells disappear after 20 days. No difference was observed in the fibronectin biosynthesis from both cell lines; however, the glycosylation degree was higher in Regb than in Prob cells indicating probable differences in the posttransductional process. The analysis of the glycosylation nature shows that fibronectin doesn't bear O-linked carbohydrate chains. The fibronectin of progressive Prob cells is more sialylated than that of the regressive Regb ones. In addition, the tri- and tetraantennary glycans are more important in Prob, while the fucosylated triantennary glycans are three times higher in Regb cells.

These differences in the glycosylation state of the fibronectins could explain their differential susceptibility to the proteases treatment. In fact, the low glycosylated fibronectin from the progressive Prob cells was more rapidly degraded by several proteases than that of regressive Regb cells. The identification of the specific sites of proteolytic cleavage by sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that the cell attachment domain as well as the collagen binding domain of Regb cell fibronectin are particularly protected against proteolytic degradation.

1 This work was supported by Grant 415/86 64.47 from the Association pour la recherche sur le cancer.

2 To whom requests for reprints should be addressed.

Received 7/11/88. Revised 5/ 8/89. Accepted 6/27/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.